FUJIFILM Holdings Corporation

SUSTAINABILITYREPORT

2021
SVP Stories

Contents / Editorial Policy
Contents
Introduction

Activity Report

Technologies and Business Fields..........................................................04

Progress of Sustainable Value Plan 2030 (SVP2030)..............................14
Feature 1: Taking Environmental Action Through Our Business.............16
Feature 2: Accelerating Solutions to Social Issues with DX....................23
Feature 3: Fighting Against COVID-19....................................................29
Appraisals and Awards ...........................................................................33
Social Contribution Activities..................................................................34

Top Management Commitment...............................................................06

Medium- to Long-Term Vision
Bringing about a Sustainable Society through Innovation......................08
SVP2030 and Priority Issues...................................................................10
Medium-Term Management Plan “VISION2023”....................................12

Editorial Policy• FUJIFILM Holdings Sustainability Report 2021 comprises two partsin response to recent demand for information disclosure. One isManagement Performance and the other is SVP Stories. Overviewsof each part follow.

Reportoverview

Management
Performance

SVP Stories

The results of FY2020 activities
systematically cover each aspectof ESG (environment, social andgovernance), based chiefly on
data. Additionally, sustainability
accounting showing activity resultsin numerical figures and third-party
assurances are shown at the end.

The sustainability scenario isdescribed as concrete actions
toward SVP2030. The 2021
edition includes an overview of
the activities in FY2020 (Pages
14–15) and special content
covering our wide-ranging
activities centered on the
keywords of the environment,
digital transformation (DX) andthe COVID-19 pandemic (Pages
16–32).

Tables are used for basic

Improved approach, related policies,
readability overview, etc., to make the data
provided easier to understand.

The main results achieved withrespect to priority issues in fiscal
2020 are summarized in a list
and our areas of focus arepresented in three
special features.

• Our Sustainable Value Plan 2030 (SVP2030) is a long-term plan with thesame target year as the Paris Agreement and the SDGs. The plan, which
was announced in August 2017 together with our medium-term
management plan, VISION 2019, was created based on the CSR issues
that have high materiality for both the Fujifilm Group and its stakeholders

from the environmental and social aspects out of the three fields of ourbusiness activities. In its development, these issues were linked to thoseof the 17 SDGs that we can contribute.
•T o increase accessibility to the topics from the CSR issues, they areassociated with the GRI standards. Further, continuous third-party
opinion has been consulted on environmental and social data to ensure
objective assessment and data accuracy.
•F or readers who are interested in more extensive information, visit our
website that also contains archived data for the last five years. You canfind the Integrated Report in the IR Materials on the FUJIFILM Holdings
website. Fujifilm, FUJIFILM Business Innovation and other businesscompanies have their own CSR websites for proactive disclosure of
information. For more details on their CSR activities, please refer to eachcompany’s official website.
•P lease note that FUJIFILM Holdings has obtained independent
assurance of the following information.
•F or details on the boundaries for each topic, please refer to thefollowing website:
https://holdings.fujifilm.com/en/sustainability/evaluation
Scope of Independent Assurance
Stakeholder management process for the report / Greenhouse gases
emissions [Scope 1 (including CFC), 2 and 3 (Category 1)] / Energy
consumption / Volumes of water intake and discharge / Volume ofwaste generated / Volume of VOC emissions / Data on personnel andlabor / Management systems supporting the reporting process

Process of Creating the Report
Communication (using tools such as dialogue meetings, surveys and inquiries)

Stakeholders
Use ascommunication tools
October 2020

FUJIFILM
Holdings

November to December

January 2021

Publishing the2020 report

Receiving
improvement proposals
from third parties

Formulating theeditorial policy

Use ascommunication tools

Incorporation of
improvement proposals

Group companies

FUJIFILM Holdings Corporation

February to July

SeptemberInterviewing
individual
departments

Publishing the2021 reportCollection and provisionof information

Use ascommunication tools

Daily business operation (CSR activities)• Period covered by the report
Fiscal 2020 (April 1, 2020–March 31, 2021) is covered in the performancedata. With regards to the contents of activities, wherever possible, wehave conveyed the most recent trends, including activities in fiscal 2021.
• Organizations covered by the report
The Fujifilm Group (FUJIFILM Holdings and all the
consolidated companies)◎Major consolidated companies are shown on our website.
https://holdings.fujifilm.com/en/about/affiliates• Date of publication (SVP Stories in Japanese/English)
September/Ocboter 2021 (Previous report: October 2020)2

Use ascommunication tools

Incorporation of opinions• Referenced standards and guidelines◎Japan’s Ministry of the Environment: Environmental Reporting
Guidelines (2018 Version) / ◎GRI: The GRI Sustainability ReportingStandards (core compliance) / ◎SASB (Sustainability AccountingStandards Board) ◎Japan’s Ministry of the Environment: Environmental
Accounting Guidelines (2005 Version) / ◎ISO 26000: Social Responsibility• Supplemental information regarding reported matters◎The term “employees” refers to all employees, including managers,
general employees and part-time staff. The term “company employees”
indicates employees (full-time staff).

The Fujifilm Group’s Commitment
Our Purpose
Corporate Philosophy

VisionWe will use leading-edge, proprietary technologies
to provide top-quality products and services that
contribute to the advancement of culture, science,technology and industry, as well as improved healthand environmental protection in society.
Our overarching aim is to help enhance the qualityof life of people worldwide.

Anchored by an open, fair and clear corporate
culture and with leading-edge, proprietary
technologies, Fujifilm is determined to remain aleading company by boldly taking up the challenge
of developing new products and creating new value.

Corporate Slogan

How We Act
Charter for Corporate Behavior

Code of Conduct

Based on the following six principles, the Fujifilm Group
respects human rights and maintains compliance with aswell as respects the spirit of all laws and international rules
in its global business activities. Beyond this, we will takeproactive action toward the realization of a sustainable
society through innovation, while taking into account the
impact of our activities.

In all aspects of our corporate activities, we emphasize
compliance and endeavor to create new value. If compliancerequirements conflict with business profits or the demandsof third parties, we give priority to compliance. An open, fair,and clear corporate culture is the basis for all our activities.

1. A Trusted Company
2. Social Responsibility
3. Respect for Human Rights
4. Global Environmental Conservation
5. Vibrant Workplaces
6. Management of Various Crises• Respect for Human Rights• Fair Corporate Activities• Protection / Preservation of Corporate Assets
and Information• Measures Related to Environmental Issues

How We Will Achieve Our Purpose
CSR Plan

Sustainable Value Plan 2030
With fiscal 2030 as its long-term goal, this plan lays the foundations of the Fujifilm Group’s business management strategies forsustainable growth. In this plan, we have set targets in the four priority areas of the environment, health, daily life and work style, as
well as in supply chain and governance, the basis of our business activities. These targets serve as guideposts toward our goal ofcontributing to the realization of a sustainable society through the dual standpoints of resolving social issues through our businessactivities and considering society and the environment in our business processes.

Medium-Term Management Plan

VISION2023
In April 2021, the Fujifilm Group formulated a specific action plan for achieving the goals set forth in the Sustainable Value Plan 2030.

Sustainability Report 2021

3

Introduction

Technologies and Business Fields
The Fujifilm Group applies advanced proprietary technologies cultivated through the photographic
film business to a wide range of business domains. We also combine these with outsidetechnologies through open innovation as we continue to create new value that will bring about
a positive impact in society.

Proprietary Technologies of the Fujifilm Group
Since our founding, we have been accumulating the base technologies to support our business, includingorganic and inorganic materials chemistry, optical technologies and analytical technologies. Based on thesetechnologies, we have honed our proprietary core technologies, which are central to continuously building up ourcompetitive advantage. By combining these technologies, we provide a wide range of products and services.

HealthEnvironment
Principal Products
and Services
Functional cosmetics

Sensor film for touch panels

Supplement products

Functional Values
Deliversolids andliquids

Cells and cell culture
media for drug
development support

Display materials

ControllightCoreTechnologies
Grain Formation

Redox
Control

Contract development
and manufacturing forbiopharmaceuticals

Handlecells

Nano Dispersion

Film Formation

Imaging

OpticsBioengineering

SoftwareAnalysis

Digital color multifunction
devices

Display
imagesFunctional
Molecules

Electrical,
Electronic

MEMS
High-Precision
Forming

Data storage media

Production
SystemSystemDesignTransfer
information

Recordimages andinformation

Functional
Polymer

Biochemistry Mechanical
DesignHighly sensitive virus
detection and analysis
equipment

High-Precision
Coating

Base Technologies

Materials
Chemistry

Semiconductor materials

CreateimagesInstant photo system

Imaging

Inkjet digital press

Captureimages

Production printers

3D medical-use PACS

Optical lenses

Work Style
4

FUJIFILM Holdings Corporation

Endoscope systems

Digital cameras

Daily Life

Introduction

Medium- to LongTerm Vision

Activity Report

The Fujifilm Group’s Business Segments
With the establishment of the medium-term management plan “VISION2023” in fiscal 2021, the business was
reorganized into four segments: Healthcare, Materials, Business Innovation and Imaging. We have createda solid business portfolio by generating synergy between these four segments sharing our core technologies.

Healthcare

Providing a wide range of businesses in the fields of prevention,
diagnosis and treatment as a total healthcare company

Medical-use picturearchiving andcommunication system(PACS)

Bio CDMO
Process development and manufacturingservices for high-quality biopharmaceuticals
in growing demand and gene therapy drugs

Life Sciences

Global market shareNo. 1*1

Medical Systems
Various diagnostic equipment such as
X-ray imaging, endoscopes and ultrasound,and medical IT systems for centralized
management of diagnostic images andother data

Medical-use PACS SYNAPSE

Total solutions in the fields of iPS cells,
culture media and reagents for drug
development support

Pharmaceuticals
Process development and manufacturingservices for next-generation nucleic aciddrugs and mRNA vaccines

Consumer Healthcare
Functional cosmetics such as the ASTALIFT
brand and supplement products

Materials Various advanced materials and graphic communication solutions
Protective film
for polarizers
Global market shareNo. 1*1
Color photoresists forimage sensors
Global market share

FUJITAC protective fi lm
for polarizers

No. 1*1

Business Innovation
Multifunction devices

Display Materials
Materials for LCD panels, organic EL panelsand other products

Other Advanced Materials

Graphic Communication

Fine chemicals (advanced chemicals,
reagents for research use, etc.), industrial
products such as sensor fi lm for touch
panels and recording media

Graphic communication solutions (offset
printing equipment, digital printing systems,etc.) and inkjet solutions such asindustrial printheads

Products and solution services that bring about newchanges in work styles, improving productivity andinspiring creativity
Office Solutions

Market share in sales volume
in the Asia-Pacific region

No. 1*2

Electronic Materials
Various materials (photoresists, CMP slurries,etc.) used to manufacture semiconductors

Multifunction devices, printers,
consumables and document solutions

Business Solutions
Solution-oriented document services
tailored to various industries and operations,
including system integration, cloud services,management of multifunction devices, andbusiness process outsourcing

Apeos C7070

products and services related to photographs andImaging Various
videos from shooting to printing
Instant photo system
Cumulative worldwide
sales volume
Over

50

Consumer Imaging

Professional Imaging

instax, color fi lms, color paper forphoto printing, developing and printing
systems, photo printing services and more

Ultra-high image quality GFX Series
cameras, compact, lightweight and highimage quality X Series cameras, TV andcine lenses, security lenses, machine visionlenses, projectors and more

million units
insta x mini 11*1 According to a survey by Fujifilm *2 According to a survey by FUJIFILM Business Innovation

Sustainability Report 2021

5

Introduction

Top Management Commitment

Making Contributions with Values That Can Only
Be Delivered by the Fujifilm Group as a Company
Indispensable for a Sustainable Society
Never stop our efforts to resolve social
issues, even during
the COVID-19 pandemic
The COVID-19 pandemic is showing no signs ofslowing down, and continues to deal a significant
impact on all aspects of people’s lives, living,education and work styles globally. Since theoutbreak of the disease in early 2020, all economic
activity as well as various initiatives to achieve theSDGs have come to a grinding halt, leaving many tore-examine the roles of business enterprises.
Over the past year, the Fujifilm Group has madeall-out efforts in helping the world overcome
COVID-19, such as contract manufacturing of active
ingredients in vaccine candidates, developing AIbased diagnostic imaging support software forpneumonia, and developing and supplying reagentsfor detecting new virus mutations. Having reinvented
itself from a photographic film company into a
corporation with a focus on the healthcare andadvanced materials businesses, Fujifilm is now feelingthe responsibility of contributing to society throughbusiness activities more than ever before. As theworld moves toward a post-COVID world, there is a
growing “Green Recovery” trend of seizing thisopportunity to build a more resilient society, capableof addressing social issues including global warming.
As a corporate citizen, Fujifilm will continue to work
toward resolving such social issues. I am pleased toconfirm that Fujifilm, as a signatory company, will also
continue to support the Ten Principles of the United
Nations Global Compact in the areas of Human
Rights, Labour, Environment and Anti-Corruption. We
remain committed to accelerating our efforts in all
corporate activities to realize a sustainable society.

Making a fresh start with the new
medium-term management plan
“VISION2023” to achieve goals set out in
the CSR plan “SVP2030”
In 2017, Fujifilm drew up the CSR plan “Sustainable
Value Plan 2030 (SVP2030),” setting out goals to be

6

FUJIFILM Holdings Corporationachieved by 2030 in four priority areas (Environment,
Health, Daily Life and Work Style) and basis of ourbusiness activities (Supply Chain and Governance),
to be approached from the perspectives of “resolvingsocial issues through business activities” and“considering society and the environment in ourbusiness processes.” For the last four years, we havecarried out activities based on the medium-term
management plan “VISION2019” to enhance a farreaching business portfolio and established a robust
business foundation that is resilient even to thepandemic. The new medium-term management plan
“VISION2023” was announced in April 2021 as thenext step toward achieving goals set out in SVP2030.
Climate-related initiatives, to be implemented in
the area of “Environment,” include raising the CO2
emissions reduction target* from 30% to 45% acrossthe entire product lifecycle (30% reduction target
already achieved in fiscal 2019), and increasing theCompany’s contribution to reducing CO2 emissions
generated in society from 50 million tons to 90 million
tons. The emissions reduction target of 45% has beenrecognized by the international environmental initiative
Science Based Targets (SBT) as WB2°C (well-below 2
degrees Celsius), i.e., science-based targets forachieving the 2°C targets adopted in the Paris
Agreement. Furthermore, we have begun our study
for a 1.5°C aligned science-based target. Based onthese efforts, we continue to enhance scenario
analysis in line with the TCFD (Task Force on Climaterelated Financial Disclosures) recommendations.
*Fiscal 2030 targets in reference to the fiscal 2013 level

In the area of “Health,” Fujifilm has set the target of
expanding the deployment of its AI-based medical
products and services from 57 countries and regions infiscal 2019 to 196 in fiscal 2030 with the eventual goalof their introduction to all countries and regions. We will
actively provide technical guidance to physicians andlaboratory technicians who handle medical devices inorder to enhance medical access and quality ofhealthcare in regions with poor access to healthcare,
thereby resolving regional disparity in healthcare
services.
In the area of “Daily Life,” as digital transformation(DX) advances in our society, Fujifilm will contribute toIntroductionbuilding a safe and secure society and peaceful living,
adopting a variety of approaches including developing
electronic materials for cutting-edge semiconductorsthat are essential for the development of 5G,
autonomous driving, etc., promoting the introduction ofrecording media and display materials that facilitate
data-oriented society, assisting the digitization of thecommercial printing and package printing, and creatingproducts and services in the photographic andvideographic fields that enrich our lives.
In the area of “Work Style,” Fujifilm will enhance
its solution delivery, aiming to offer productivity
improvement and work styles that facilitate creativity
to some 50 million workers. This initiative will be led
by FUJIFILM Business Innovation (formerly known as
Fuji Xerox, renamed in April 2021) to literally offer
innovation-delivering values to client businesses.
This fiscal year, Fujifilm has established a new
management structure to further clarify the roles ofmanagement execution and supervision. The Boardof Directors is now tasked to monitor whether theCompany is acting in line with policies set out in themedium-term management plan, functioning fairly toall stakeholders and operating in a direction
consistent with values sought by society. This way,
we will apply corporate governance that does nothinder business expansion and boosts transparency.

Medium- to LongTerm Vision

Activity Reportof (1) accelerating our business growth centered onhealthcare and advanced materials areas andimproving profitability and efficiency in other businessareas, (2) promoting group-wide DX, and (3)developing and reinforcing human resources capableof achieving results in the global arena. Regarding (2),
we have already announced the establishment of the
Fujifilm Group DX Vision in July 2021 and launched acompanywide initiative “All-Fujifilm DX Promotion
Program” under my direction to encourage allbusiness divisions to identify and tackle DX issues. I
will work on these challenges in the effort to apply
Fujifilm Group’s strengths to creating social values.
In order to change society for the better, the Fujifilm
Group needs to be able to create change constantly.
Under the slogan of “NEVER STOP,” we will take onchallenges and continue growing, so as to further
contribute to establishing a sustainable society byproviding outstanding value.
September 2021

Continuing to grow and offer value
in order to generate positive changes
in society
The Fujifilm Group is capable of deploying a diverse
range of businesses and contributing to resolving a
range of social issues from various angles. In order tocontribute to society in four priority areas(Environment, Health, Daily Life and Work Style) andaccelerate global business deployment, we must
further use AI technology and ICT to streamline work
processes, create group-wide business synergy andfoster diverse human resources who can workrelentlessly toward our goals. To this end, in assuming
the position of CEO, I have declared my commitment

Teiichi Goto
President and CEO

Sustainability Report 2021

7

Medium- to Long-Term Vision

Bringing abouta Sustainable Society
through Innovation

The Fujiﬁlm Group’s business originated with photographic ﬁlm, a productfor which lots of clean water and fresh air are essential to the manufacturing
process. It is also a product which requires customers to “buy on trust,” since
they cannot try it out beforehand.
Thus, for the Fujiﬁlm Group, environmental conservation and maintaining
the trust of stakeholders have been the very foundations of our businessactivities since the beginning. They are the starting point for our corporatesocial responsibility (CSR) activities and continue to be passed down within ourGroup, as the Fujiﬁlm Group’s “DNA.”We will contribute to the sustainable development of society by putting our
Corporate Philosophy into practice through sincere and fair business activities,
never forgetting our starting point.
The Fujifilm Group’s Approach to CSR

8

FUJIFILM Holdings Corporation

Introduction

Medium- to LongTerm Vision

Activity Report

Resolving global environmental andsocial issues with innovation
We believe creating value through innovation, to resolve
issues faced by international society such as climatechange, poverty and healthcare and to enrich society
as a whole, is the essence of corporate management.

Impacting society in a positive way
through a wide range of businesses
We will provide new value in our diversiﬁed businesses
to create positive changes in society by combining our
proprietary technologies that we have cultivated over theyears with advanced technologies such as AI.

Adequately responding to the
expectations of society throughstakeholder engagement
Through communication with diverse stakeholders, wewill continually reassess whether or not we are adequately
responding to the expectations of society. And then, we
will contribute to society as a sustainable company.

Sustainability Report 2021

9Medium- to Long-Term Vision

SVP2030 and Priority Issues
Under the CSR plan “Sustainable Value Plan 2030 (SVP2030),” which outlines our long-term vision
targeting fiscal 2030, we will use leading-edge, proprietary technologies to provide top-quality
products and services. By doing this, we will work to resolve social issues through our businessactivities and contribute to the realization of a sustainable society.

Fiscal 2017: Formulation of SVP2030

VISION2019

VISION
2023

SVP2030 Priority Areas and Priority Issues (Materiality)
Targets are set in four priority areas and in the basis of our business activities via a two-pronged approach:considering society and the environment in our business processes and resolving social issues throughour business activities.

Priority Areas

Priority Issues

Environment

1. Address climate change
2. Promote recycling of resources
3. Address energy issues toward a decarbonized society
4. Ensure product and chemical safety

Health

1. Fulfill unmet medical needs
2. Improve accessibility to medical services
3. Contribute to identifying diseases at an early stage
4. Contribute to health promotion and beauty
5. Promote management of a healthy workplace

Daily Life

1. Contribute to creating a safe and secure society
2. Contribute to enriching humanity and relationships
between people

Work Style

1. Create environments that lead to a motivatedworkplace (provision of solution services)
2. Develop and utilize diverse human resources

Basis of Business Activities

10

FUJIFILM Holdings Corporation•Supply Chain

Strengthen CSR foundations across the entire supply chain
including factors of the environment, ethics, and human rights•GovernanceImprove and maintain governance structures by further
disseminating an open, fair and clear corporate cultureIntroduction

Medium- to LongTerm Vision

Activity Report

Realization ofa Sustainable Society
through

SVP
2030
SVP2030

VISION2023

Long-term goals
targeting fiscal 2030

An action plan for achieving
the goals in SVP2030

Process for Identifying Materiality

Resolving social
issues throughbusiness activities

Considering society
and the environment
in our businessprocesses

Contribution(Opportunities)

Impact(Risks)

●
●
●
●

●
●

●
●
●
●

●

Have a long-term perspective to contribute toresolving social issues as a global company andshow the future vision clearlyBusiness
Segments▶Healthcare▶ Materials▶ Business Innovation▶ Imaging

Goals in the
SDGs
Step 2Extracting Social Issues Based on
Business Strategy

List issues from external perspectives (e.g.
guidelines such as ISO 26000, GRI and theSDGs) and in terms of potential issue resolution
by all our divisions▶Healthcare
Step 3
Evaluation of Materiality●(Employees)●●●

Step 1Clarifying the Basic Policies▶Materials▶Imaging●(Employees)●(Employees)

Evaluate materiality via a two-pronged approach:(1) Considering society and the environment inour business processes(2) Resolving social issues through our businessactivities▶Business Innovation
Step 4
Planning and Review

Promote measures as companywide policy after
coordinating goals for identified materiality withthe relevant business divisions and finalizing
materiality in the deliberations at
the ESG Committee* For details of each step, see Section 1.2.4 in the
Sustainability Report 2021, Management Performance.

Sustainability Report 2021

11

Medium- to Long-Term Vision

Medium-Term Management Plan “VISION2023”
In April 2021, we announced our medium-term management plan, VISION2023, which concludes
in fiscal 2023. Over the three-year period that began in fiscal 2021, we will invest a total of JPY 1.2
trillion yen to accelerate growth, primarily in the healthcare and advanced materials fields.
We will establish a more robust business foundation to enable sustainable growth.

Accelerate business growth in healthcare and advanced materials andbuild a more resilient business platform to facilitate sustainable growth• Continue active growth investments• Concentrate management resources on “New/Future Potential” and“Growth Driver” businesses• Accelerate and strengthen the cash generation andinvestment cycle

Priority Measures

1 Reinforce business portfolio management

2 Strengthen cash flow management

Implement appropriate strategies according tobusiness phase

Thorough business approach that emphasizes
capital efficiency

Optimal allocation of groupwide management resources

Improve ROE*1, ROIC*2 and CCC*3

3 Enter into new markets for further growth

4 through M&A

Continue to invest in fields and markets where ourtechnological strengths*4 can be leveraged

FUJIFILM Healthcare*5→Combine AI technology with our extensive
product lineup to create new value

Create stronger integrated business synergies

FUJIFILM Business Innovation→Accelerate global business deployment→Strengthen solution and service businesses*1 Return on equity*2 Return on invested capital*3 Cash conversion cycle. Number of days from when payment is made to purchase raw
materials to when payment is collected for products or services

Healthcare*4 AI/IT technologies, biotechnology, optical control material technology, etc.
*5 Successor company for diagnostic imaging-related business of Hitachi, Ltd. acquired on
March 31, 2021

Materials

BusinessInnovation

Imaging

Proprietary technologies developed while
diversifying businesses based on technologies
cultivated in photographic film

12

FUJIFILM Holdings Corporation

In our businesses, we share the proprietary
technologies we have developed while diversifying
our businesses based around photographic film,
and the technologies that serve as the foundationfor various businesses are connected like theroots of a tree. Through these sharedtechnologies, we are building a business portfolio
for realizing groupwide growth by efficiently
developing businesses in four domains thatappear different at first glance.
Under VISION2023, we seek to further solidify
this business portfolio. Our framework for this isaccelerating business growth in healthcare andadvanced materials and building a more resilientbusiness platform to facilitate sustainable growth.
To achieve this, we are promoting the above fourpriority measures.

Introduction

Medium- to LongTerm Vision

Activity Report

In addition to establishing VISION2023, we reorganized our business into four segments (see below). As of
fiscal 2021, sales, operating profit and other financial information is disclosed for healthcare as an independent
segment. We plan to grow it into our largest segment in terms of revenue and operating income by fiscal 2023.
Reorganizing into four business segments

Healthcare■ Medical Systems■ Bio CDMO

Advanced Materials■ Life Sciences

・Life sciences(drug discovery support: iPS cells, cell culture media, reagents)
・Pharmaceuticals
・Consumer healthcare (cosmetics, supplements)■ Other Advanced
Materials■ Graphic Communication
・Graphic communication
・InkjetMaterials■ Electronic Materials■ Display Materials

BusinessInnovation■ Office Solutions■ Business Solutions

As of fiscal 2021, results aredisclosed for four segments(healthcare, materials, business
innovation and imaging) and 11
subsegments ( ■ ■ ■ ■ )*Imaging■ Consumer Imaging■ Professional Imaging* Revenue and operating income aredisclosed for the four segments, andrevenue is disclosed for the
11 subsegments.

・Industrial materials
・Fine chemicals
・Recording media

Furthermore, for each business categorized as “New/Future Potential,” “Growth Driver,” “Earnings Base” or“Non-core,” we will implement appropriate strategies according to the respective growth phase and reallocate
groupwide management resources.

Low

Market attractiveness (growth potential)

High

Planting seeds from a long-term perspective

Driving growth and profit in the medium term

New/Future Potential

Growth Driver■ Medical Systems:
AI/IT systems, endoscopes (rigid endoscopes, surgical tools)■ Bio CDMO:
Gene therapeutics CDMO
■ Life Sciences:
Drug discovery support (iPS cells, cell culture media, reagents)■ Electronic Materials, Display Materials and Other Advanced
Materials:
New materials■ Graphic Communication:
Digital printing, inkjet■ Business Solutions etc.

■ Medical Systems:
Endoscopes (flexible endoscopes, treatment tools)
IVD (equipment, reagents)
Diagnostic ultrasound systems (POC, stationary)
X-ray equipment (CT, MRI, DR, etc.)■ Bio CDMO:
Antibody drug CDMO
■ Electronic Materials:
Semiconductor materials

etc.

Non-core

Earnings Base (cash cows)

Judged based on compatibility with strategy, growth potential
and profitability■ Office Solutions■ Consumer Imaging■ Professional imaging■ Graphic Communication:
Analog printing  etc.

High

Our profitability
The arrow () indicates the flow of management resources, including cash

The Fujifilm Group is actively engaging in capital investment and M&A to achieve further growth. Sufficient
cash is essential for investment, so we must expand profits and improve our cash generation capabilities. We
will engage in a thorough business approach that emphasizes capital efficiency, track the efficiency of eachbusiness activity not only by ROE but also by ROIC and CCC, and pursue further improvement ofcorporate value.
We will also aim to achieve both the improvement of customer satisfaction and cash generation throughoperations to deliver products at the required time and in the required amount without keeping inventory.
Sustainability Report 2021

13

Activity Report

Special feature 1

The CSR Plan,
Sustainable
Value Plan
2030Plan 2030
Progressof
Sustainable
Value(SVP 2030) and Priority Issues (Materiality)
In Support
fiscal 2020,
Fujifilm
Groupcarriedout various
activities
in line with
the Group’s
plan,
the thetangibleandintangible
aspectsof social
infrastructure
in people’s
livesCSR
through“Sustainable
Value
Plan
2030
(SVP2030).”
Here
is
a
summaryofactivitiesbymaterialityinfourvarious products, services and technologies.
priority areas and the basis of our business activities.

Environment
Field

Targets for FY2030

Targets

Index

Unit

Reduce CO2 emissions across theentire product life cycle*2 by 45% by
FY2030, compared to the FY2013 level

Rate forreduction
in CO2emissions

Convert 50% of purchased electric
power to renewable energy-derived
power by FY2030, aiming for zero CO2emissions from energy use by 2050

Results *1

Targetvalue
for
Self2030 evaluation Progress

2019

2020

%

23

30

41

45

◎

91%

Share ofrenewableenergy

%

8

9

9

50

〇

18%

Contribute to a reduction in the CO2
emissions generated by society by 90
million tons by FY2030

Reducedvolumeof CO2emissionsmillion
ton

11

16

20

90

〇

23%

Make Green Value Products rate persales 60% by FY2030

Sales
coverage
ratio

%

ー

27

32

60

〇

53%

Reducing the amountof water the Fujiﬁlm
Group uses

Reduce the amount of water the
Fujiﬁlm Group uses by 30% by FY2030(compared to the FY2013 level)

Rate ofreduction
in water
usage

%

14

15

16

30

〇

53%

Contributing to water
treatment throughproducts and services

Contribute to the treatment of 35
million tons of water per year insociety by FY2030

Annualamountof watertreatment

million
ton

8

5

8

35

〇

23%

Reducing waste

Reduce the amount of waste generated
by the Fujiﬁlm Group by 30% by FY2030(compared to the FY2013 level)

Rate ofwaste
reduction

%

-8

-9

0

30

×

0%

Achieve recycling index: More than 10
by FY2030

Recyclingindex*3

ー

6.9

6.6

6.5

10

×

65%

Achieve valuables conversion index:More than 1 by FY2030

Valuables
conversion
index*4

ー

0.67

0.67

0.63

1

×

63%

1. Address climatechange▶P. 16–20

Contributing to reducing
CO2 emissions insociety throughproducts and services

Improving recycling
quality

3. Address energy
issues toward adecarbonized society▶P. 19Contribute to
the creation andwidespread use ofrenewable energies
through advanced
materials

4. Ensure product andchemical safety▶P. 22• Completed replacement of two of seven chemical substances within the high priority substances for
Minimize adverse effectrisk management, a classiﬁcation newly established in 2020of chemical substances• Held online brieﬁngs for business partners and achieved 90% understanding of the chemSHERPA
on human health andchemical information communication system, contributing to further improvement of management
the environment
accuracy for hazardous substances used in products• New Energy and Industrial Technology Development Organization (NEDO) commenced thedevelopment of an “all-solid-state lithium ion battery,” a next-generation storage battery for EVs,
under an industry-government-academia collaboration. Fujiﬁlm is participating in the project as oneof 23 manufacturers of cars and batteries*1 Some ﬁgures have been changed from those listed in FUJIFILM Holdings Sustainability Report 2020 due to a review of the calculation method and scope*2 Including phases such as procurement of materials, and manufacturing, transportation, usage and disposal of products*3 Recycling index = (Recycled volume + Valuable-converted volume) / Simple disposal volume*4 Valuables conversion index = Valuable-converted volume / Recycled volume

14

Fair × Poor

Againsttarget2018

Reducing the Fujiﬁlm
Group’s CO2 emissions

2. Promote recyclingof resources▶P. 21

Note: ◎ Excellent 〇 Good

FUJIFILM Holdings Corporation〇〇

New targets set in
fiscal 2020

Introduction

HealthPriority issues

Targets for FY2030

Medium- to LongTerm Vision

Activity Report

Selfevaluation

Major activities• Establish a new process development and manufacturing facility for viral vectors and1. Fulﬁll unmet
medical needs

advanced therapies at FUJIFILM Diosynth Biotechnologies in the U.K.
Develop and disseminate new treatments based • Succeeded in propagating the human norovirus using human iPSC-derived intestinal
epithelial cells
on regenerative medicine and cell therapy• Participated in the Massachusetts Center for Advanced Biological Innovation and
Manufacturing, PBLLC, an industry-academia joint research and development consortium inthe ﬁeld of state-of-the-art treatment〇(1) Reducing burden on medical professionals• Launched pulmonary nodule detection and analysis functions for SYNAPSE SAI viewer, an
by utilizing IT
AI platform, in Japan(2) Development and dissemination of
2. Improve• Launched SYNAPSE Radiotherapy, a radiotherapy planning support software that utilizes AI,
infectious disease diagnostic system toaccessibility toin Japancontribute to global healthmedical services• FUJIFILM Healthcare Corporation newly joined the Fujiﬁlm Group, adding CT, MRI and other▶P. 25,29–31
devices to the Group’s medical equipment lineup, launching higher value-added solutions(3) Offering technical diagnosis training andcentered on medical IT globallyspreading effective health practices to• Manufactured drug substance for COVID-19 vaccine candidates and provided contract
emerging countries
manufacturing for COVID-19 vaccine formulation
3. Contribute• Launched COVID-19 gene detection reagents, gene detection kits and antigen test kits
Reduce the physical burden throughto identifying• Opened a cancer-focused screening center in India
widespread and expanded use of medical
diseases at an
diagnostic systems• Expanded biopharmaceutical manufacturing facilities at the Denmark facility
early stage〇• Newly developed nanotetrahydropiperine, an ingredient that improves skin elasticity(1) Promote to prolong healthy lives
4. Contribute tohealth promotion• Clearly determined the mechanism by which melanin, which causes age spots, stays in theand beauty(2) Promote support for women’s empowerment stratum corneum〇

5. Promotemanagementof a healthy
workplace• Held health management e-learning programs for Fujiﬁlm Group employees in Japan• Internally published the Declaration of Commitment to Health by Fujiﬁlm Group ofﬁcers in Japan• Incorporated smoking ban during work hours into work regulations〇

Major activities

Selfevaluation

Promote management of health andproductivity to maintain employees’ vitality

Daily Life
Priority issues

Targets for FY2030

1. Contribute tocreating a safe
and securesociety(1) Develop technologies for products andservices and promote their greater use tocontribute to the development of ICT society • Developed technology to deliver high magnetic tape storage capacity of 580TB using
strontium ferrite magnetic particles(2) Contribute to enhancing the safety of• Enhanced AI-based functions of Fujiﬁlm infrastructure photo analysis service Hibimikke
infrastructure through more efﬁcient
inspections for the deterioration andmalfunctioning of buildings and structures

2. Contributeto enriching
humanity andrelationships
between people

Contribute to enriching and making people’s
lives peaceful through records of photos andvideos, and photographic products that give
form to memories

Work Style

Priority issues• Renewed photobook service Year Album with new personazlied fuctions leveraging AI technology• Launched instax SQUARE SQ1, a new entry model compatible with popular square format ﬁlm• Launched mirrorless digital camera FUJIFILM GFX100S with advanced portability and〇

Major activities

Selfevaluation

superior image quality

Targets for FY2030• Launched the ApeosPort, ApeosPort-VII and ApeosPort Print series, supporting individual

1. Createenvironmentsthat lead toa motivatedworkplace▶P. 27

work styles by improving operability and convenience and strengthening security• Established FUJIFILM RIPCORD G.K., a service company driving corporate digital
Contribute to generate the innovation fororganizations and society by offering solutions transformationand services that support increasing worker’s • Launched provision of IT Expert Service, an outsourcing service helping SMEs to leverage IT
productivity and exerting their creativity• Launched Cloud Collaboration Application for DX Suite, a multifunction device application
streamlining digitization of paper forms• Expanded service locations for CocoDesk private workspace that supports new work styles

2. Develop
and utilize
diverse humanresources

Create frameworks and workplaces so that
the Fujiﬁlm Group’s diverse employees mayexert their capabilities and creativity to thefullest extent

Supply Chain

Priority issues

GovernanceImprove andmaintaingovernancestructures• FUJIFILM Business Innovation Corp. opened a domestic sales Center Ofﬁce and the Bridge

for Innovation, a hands-on showroom, in Tokyo, with the purpose of putting new ways ofworking into practice and to propose optimal work styles to customers• Improved the ratio of women in managerial positions (from 14.5% in FY2019 to 15.4% in FY2020)

Targets for FY2030(1) Realize sustainable procurement
considering the environment, ethics andStrengthen CSR
human rights
foundations acrossthe entire supply
chain(2) Ensure compliance with legislation
on biodiversity

Priority issues〇〇

Selfevaluation

Major activities• Dissemination of Fujiﬁlm’s Code of Conduct, and collection of receipt: 213 companies• CSR self-check: Number of suppliers requested and response rate: 568 companies, 75%• Percentage of suppliers with 90% or higher conformance rate: 87%• Visit and check: Number of suppliers evaluated and plan achievement rate: 56 companies, 90%• Supplier response rate for conﬂict minerals survey and percentage of conﬂict-free smelters in〇

conﬂict minerals survey: 99%, 75%• Percentage of suppliers fulﬁlling Fujiﬁlm’s paper procurement requirements: 100%

Targets for FY2030

Aim for zero cases of misconduct and major
legal violations by disseminating an open, fairand clear corporate culture〇

Selfevaluation

Major activities• Revision of Corporate Governance Guidelines• Establishment of the Fujiﬁlm Group AI Policy• Establishment of the Fujiﬁlm Group Global Healthcare Code of Conduct and providing

education to employees engaged in related businesses〇• Surveying all Group employees on understanding of Company policies and awarenessof compliance

Sustainability Report 2021

15

Feature 1

Taking Environmental Action through Our Business
The Fujifithelm Grouphas
regularly
highlighted
environment
as a key
withinlong-term
Supporttangibleandintangible
aspects theof social
infrastructure
in priority
people’s
lives ourthrough
CSR
plan
and
the
medium-term
management
plan
established
to
meet
CSR
plan
goals.
various products, services and technologies.
We are addressing environmental issues directly through our business activities and actions.

Addressing Climate Change

Here is our road map and examples of activities addressing climate change, aiming for carbon neutrality.

Reducing CO2 emissions in the entire product life cycle

In-house

Manufacturing

Reducing CO2 emissions in each phase45%

� Procurement: Promote recycling of raw materials andenhance partnership with suppliers

reduction

Procurement

� Transportation: Increase efficiency

Transportation

� Product Use: Provide energy-saving products

Product Use� Disposal: Recyle waste and develop products with low CO2
emissions associated with disposal

Disposal

2013

2030

2050

Society

The Fujifilm Group will reduce CO2
emissions by 45% (compared tofiscal 2013) in the entire product life
cycle by 2030. By 2050, we aim
to eliminate CO2 emissions in ourenergy usage (Scope 1 and 2).
Furthermore, by developing andproviding energy-saving products
and services that help reduce CO2
emissions, we will promote reductionof CO2 emissions in society andcontribute to the realization of adecarbonized society.

Carbon neutrality

Reducing CO2 emissions in society

Develop and provide products and services
that contribute to energy savings and CO2
emissions reduction

Road map for reducing CO2 emissions (Scope 1 and 2)

Scope 1

Achieving zero CO2emissions from theGroup operations

Scope 2

2013

2020

2030

2050

Increase efficiency of energy supply systems
Upgrade to high-efficiency cogeneration equipment

Scope 1Develop technology

Eliminate CO2 emissions from fuels

Explore, develop and introduce new technologies for fuels that do not emit CO2

Save energy through improvements of production processes
Visualize energy using IT Design and introduce energy-saving manufacturing conditions

Switch to renewable energy (electric power)
Scope 2

Switch to renewable energy

Utilize renewable energy certificates and credits

Install renewable energy power generation equipment
Globally introduce equipment (e.g. solar power, hydroelectric power and wind power) adapted to local geographical conditions

16

FUJIFILM Holdings Corporation

Introduction

Medium- to LongTerm Vision

Activity Report

Addressing Climate Change Article 1

Choosing a location for the new facility considering
reducing CO2 emissions: Expanding the sustainable
contract development and manufactureof biopharmaceuticals
The Fujifilm Group is expanding its contract development
and manufacture of biopharmaceuticals (CDMO*)
business. The Group’s core bio CDMO company,
FUJIFILM Diosynth Biotechnologies (FDB), has fourbases of operations located in the United States, theUnited Kingdom and Denmark and meets a wide rangeof customer needs with its advanced production andquality control technologies and state-of-the-art facilities.
Because further market growth is expected, FDB
announced in March 2021 the new construction of alarge-scale cell culture biopharmaceutical manufacturing
facility—adding a second facility in North Carolina, USA.
The new facility will have eight 20,000 liters bioreactors forcell culture, a large-scale drug product manufacturing line
and a packaging line. This will make it possible to provide
complete solutions from bulk drug substance to drug
product and packaging.
When choosing the location for the new facility,
the company took its overall environmental impact on
the supply chain into account based on a life cycle
assessment, not limited to its own operations. Envisioning
supplying products to the United States, which is thehighest-demand market, several model cases wereused to estimate the CO2 emissions associated with
manufacturing, packaging and shipping. As a result, thecompany found that all models involving air transport via
European manufacturing facilities resulted in tremendous

amounts of CO2 emissions and that the model ofcompleting all processes within the United States had
the least environmental impact. In addition, at the newfacility, the company will leverage the advantages of North
Carolina’s robust state environmental programs such as
renewable energy incentives, and will actively introduce
systems that reduce environmental impact in collaboration
with the local government and its business partners.
Going forward, environmentally conscious manufacturing
will be expanded, and business growth will be accelerated
by utilizing renewable energy sources for all electric
power requirements.
* The Company offers wide-ranging services to pharmaceutical companies, from cell line
development to process development, stability testing and manufacturing of investigational
new drugs

New FDB facility to be operational in spring 2025 (Holly Springs, North Carolina, USA)

Model Comparison of Product Supply to the United States

Manufacturing everything at U.S. facilities
Manufacturing

Drug substance > Drug product > Packaging

� Electricity/gas consumption
� Waste disposal

Low environmental
impactby NOT using air transport

Manufacturing everything at the Denmark facility with high renewable energy usage and shippingto the U.S

Manufacturing

Cold storage, air transport

Drug substance > Drug product > Packaging

Denmark > United StatesHighenvironmental
impact·Electricity/gas consumption ·Waste disposal[Proportion of renewable energy use: 80%]

·Refrigerated containers

using air transport

Sustainability Report 2021

17

Activity Report

Addressing Climate Change Article 2

Fujifilm Group “Green Value Products”
Certification Program
With the aim of contributing to the realization of asustainable society, the Fujifilm Group has established
the Fujifilm Group “Green Value Products” Certification
Program as a mechanism for continuing to create
environmentally conscious products and services.
In fiscal 2020, 30 new products were certified, making
a total of 166 certified products. We also set a newenvironmental target for fiscal 2030, “Make Green Value
Products rate per sales 60%.” We endeavor to further
environmental impact reductions through our products
and services.

Fujifilm Group
Green Value Products

Products and services that use
their respective industries’
innovative technologies tosubstantially contribute to
reducing environmental impact

Diamond

Products and services that
reduce environmental impact attheir respective industries'
highest level

Gold
SilverProducts and services that
reduce environmental impact at
a higher level than theirrespective industries' standard

Standard environmentallyconscious productsThis certiﬁcation program started in 2018 and is compliant with ISO 14021(Self-declared environmental claims) to secure objectivity, reliability and transparency,with advice from Dr. Norihiro Itsubo of Tokyo City University as an external expert.

Examples of certified products and services
Gold certification: Reducing CO2 emissions in a data-driven society—Magnetic tape and data archiving solution

for its contribution to reducing energy usage at data
centers as the volume of digital data continues to increase.
Comparison of power consumption(kwh/day)10

Power consumption

Currently, the energy required to store enormous volumesof data is a social issue. In hard disk drives (HDDs) usedat data centers, the disk continually spins regardless ofwhether the data is accessed or not, requiring continuous
electric power. Fujifilm’s data archiving solution canefficiently store “cold data,” which is seldom accessed
but said to account for more than 80% of all data. Thisis because its LTO tape (large-capacity magnetic tape)uses power only when data is written to or read fromthe tape. It substantiallyreduces power consumption
by approximately 74%
compared to storing dataon HDDs. This solution was
granted a gold certification

Approx. 74％
reduction

8
6
4
2
0

HDD (200TB)

TAA (total capacity of 250TB)

Operating conditions：Calculated based on data write and non-write times, with drives
powered 24 hours a day and approximately 110GB of data written
per day
T A A data：Fujiﬁlm measurement for HDD capacity of 10TB + tape capacity of 240TB(LTO-7 x 40 drives)
HDD data：[Source] Energy Conservation with Use of Tape Storage 2016, JEITA Data
Storage Technical Committee

Gold certification: Telecommuting solution “beat” reduces human travel and use of office equipment

Since 2020, telecommuting has been spreading rapidly
due to the COVID-19 pandemic, and work styles havebeen changing. However, there are still many companies
that have not adopted it due to concern over security risks.
FUJIFILM Business Innovation’s telecommuting solution“beat” is a service that provides comprehensive support
for secure, simple and convenient network management.
It enables a comfortable and safe network environment
with its strong security system, a one-stop solution for
24/7 monitoring of network operations, and the flexibility toconnect internal and external networks. This solution was
granted a gold certification since it reduces the workloadof introducing telecommuting, thus contributing to the
reduction of CO2 emissions with less human travel and useof office equipment.

18

FUJIFILM Holdings Corporation

SecureSolid security system within-depth defense

SimpleConvenient

Reduced burden of
network operations
via outsourcing

Remote access service
enabling flexible
working environment

Expected ﬂ ow of network management outsourcing
Beat Contact Center
Technical support and phone support
in the event of failure

Error detection

Beat Network
Operations Center

Beat-box
24/7 remote monitoring andautomatic software updates

Internal LAN

Introduction

Medium- to LongTerm Vision

Activity Report

Addressing Climate Change Article 3

TAC film produces lower CO2 emissions when
disposed of
The Fujifilm Group develops, manufactures and sells
triacetylcellulose (TAC) film (product name: FUJITAC), a
protective film for polarizers that is indispensable in LCD(liquid crystal display) and OLED (organic light-emitting
diode) display polarizers (filters that allow light through only
in a specific direction). It has superior optical properties
and smoothness as well as high transparency, so it is also
used as a substrate for high-performance coating film.
The film is made from cellulose produced from
non-edible plants. Around 50% of the CO2 emissions
associated with its disposal are excluded in the total
emissions since the emissions from biomass are
deducted. For that reason, compared to PET*1, COP*2,
acrylic and other petroleum-derived films, TAC film is now
attracting attention from an environmental perspective
as well.
By further expanding the provision of TAC film
products, we will contribute to reducing CO2 emissions
in society.
*1 Polyethylene terephthalate *2 Cyclic olefin polymer

Liquidcrystal cell

TAC ﬁlm(Product name: FUJITAC)

Polarizer

CO2 emissions from waste disposal(CO2-kg/Film-kg)

Biomass Mark

Biomass ■Non-biomass

3.5
3.0

Deductedfrom totals

2.5
2.0
1.5

In 2006, Fujifilm received biomass productcertification from the Japan Organics Recycling
Association for TAC film.

Polarizer

1.0
0.5
0.0

0.9

3.2

2.3

2.2

0.9
TAC

PET

COP

Acrylic

Note: CO2 emissions calculated using general structural formula for each material.
Deducted amount for TAC film calculated from biomass material ratio (weight ratio).

Addressing Climate Change Article 4

Gas separation membrane formation technology
contributing to the transition to a decarbonized society
Natural gas emits less CO2 compared to other fossil
fuels such as petroleum and coal, and is considered to
be an energy resource that will lead to reduction of CO2
emissions in the transition period toward the realization ofa decarbonized society. The Fujifilm Group has developed
and provided CO2 separation membranes that separate
impurities such as CO2 from natural gas. This process
utilizes membrane formation technology leveraging highprecision coating and chemical design technology. By
applying these technologies to develop membranes withvarious properties, we aim to purify and generate energy
resources that do not emit CO2 such as hydrogen. We
will continue our efforts to realize decarbonization in theenergy domain.

Separation membrane for natural gas puriﬁcation

Sustainability Report 2021

19

Activity Report

Addressing Climate Change Article 5

Initiatives at each Fujifilm Group site
FUJIFILM Toyama Chemical Co., Ltd.

Reducing CO2 emissions by converting to city gas

The Toyama Daiichi Plant of FUJIFILM Toyama Chemical
converted its fuel for boilers from heavy oil to city gas,
resulting in a 1,052-ton reduction in CO2 emissions per
year. Since 2003, the Fujifilm Group has been proactively

converting the fuel for in-house cogeneration systems andboilers from heavy oil to city gas. Now, approximately 90%of the fuel we are currently using is derived from natural gas,
which has lower CO2 emissions.

Fuel equipment at Toyama Daiichi Plant

FUJIFILM Toyama Chemical members

FUJIFILM Optics Co., Ltd.

 our facilities come together to engage inFenergy-saving activities

FUJIFILM Optics is promoting energy-saving activities
companywide. With four facilities each doing their partin improving energy savings, the company reduced its
CO2 emissions by 2,300 tons compared to the previous
year. One of the measures is the visualization of power
consumption at the Sano Site in Tochigi Prefecture. A
fundamental review was conducted on the equipment
operating conditions, particularly the air conditioning
equipment in the clean room, which accounted forroughly 45% of the department’s power consumption. By
optimizing the temperature settings and operating times
by production area, they were able to reduce their overall
power consumption by 16% compared to theprevious year.

Energy-savings promotion members

FUJIFILM Corporation

Reducing electric power by improving
efficiency of cooling

The Kanagawa Factory of FUJIFILM Corporation supplies
the heating and cooling sources used at manufacturingbuildings via a central cold water system. In fiscal 2020,
power consumption was reduced by further consolidating
freezers throughout the worksites and introducing highefficiency turbo freezers that use inverter control toeffectively utilize low-temperature cooling water. For
the year, a 240-ton reduction of CO2 was achieved.

20

FUJIFILM Holdings Corporation

Kanagawa Factory members

Introduction

Medium- to LongTerm Vision

Activity Report

Promoting Environmental Conservation andRecycling of Resources
Utilizing ICT to prevent problems
Faster initial response when water
quality changes
Monitoring
Sends alert automaticallyapparatus
detects
abnormalityand displays
measurement values

Fasterinitialresponse

The Fujifilm Kanagawa
Factory used toCheckrespond to night-timestatusremotelyproblems in the river
within the premises
River running through the factory
only after arriving on
Automatic alert system
site upon getting an
emergency call. With improvements, the related data is now
managed via ICT and accessed remotely, allowing for quick
understanding and response to problems.

Monitoring smoke and soot 24/ 7

At the Fujifilm Fujinomiya Factory, surveillance cameras
have been installed tocheck the conditionsof boiler combustionand smoke and sootcoming out of thechimney. Monitoringtakes place 24/7 at aremote control center.

Multifunction device certified asGreen Design Product in China
DocuCentre-VII C3372 digital color multifunction device
was certified as a Green Design Product by the Ministryof Industry and Information Technology of the Chinese
government in 2020. It was the first multifunction deviceof a foreign company in China to be certified as such. In
addition, FUJIFILM Manufacturing Shenzhen Corp, which
manufactures the product, was certified as a Green Plant
in 2019.
The Chinese government is promoting green
manufacturing based on the national policy “Made in
China 2025” and is certifying Green Design Products andGreen Plants. Green Design Products are evaluated basedon their environmental impact throughout their life cycle,
from product design and development to manufacturing,shipping, use,maintenance andrecycling. The
Fujifilm device was
rated highly for its
recycling-friendly
design, energy-saving
performanceand quietness.
Green Design Product certiﬁcate

In-house treatment of wastewaterproduced when manufacturingconductive film
EXCLEAR is a low-profile, double-sided sensor film
for touch panels. Previously, it was difficult to treat thewastewater produced when manufacturing this conductive
film, so the process had been outsourced. At the Fujifilm
Kanagawa Factory Ashigara Site, acclimatizing active
sludge* to the composition of the wastewater enabled
treating all wastewater in house. This reduced the total
amount of waste discharged from the factory by around
25% (compared tothe previous year).

Joint wastewater treatment withneighboring companies
At the FUJIFILM Manufacturing Europe B.V. Plant in
Tilburg, Netherlands, a large-scale water treatment facility
was constructed on the premises in 2016, and it is used
jointly with three neighboring companies. It employs themembrane bioreactor treatment method, which is rare in
the Netherlands, and is capable of treating 10 million litersof water per day. Purifying wastewater from four companies
in a safe and efficient way contributes to reducing the load
placed on wastewater treatment facilities in the region.

* By adding chemicals to theactivated sludge a little at atime, microorganisms that break
down those chemicals arecultivated, increasing thecapacity to break them down.

Ashigara Site members

Sustainability Report 2021

21

Activity Report

Chemical Safety Managemant

Contributing to reduction of environmental burden
and advancement of R&D such as in pharmaceuticals
with a proprietary new peptide synthesis process
The Fujifilm Group launched contract development andmanufacturing services for peptides for pharmaceuticals
and cosmetics in 2019.
Peptides are protein fragments composed of chainsof amino acids. Peptides with the complicated structures
required for developing pharmaceuticals and biomaterials
are difficult to synthesize using conventional methods, andthe amount of solvent used increases in the purification
process to increase purity, so there is also a significant
environmental burden caused at the time of disposal.
The advantages of the synthesis process developedby Fujifilm over conventional methods include being able
to manufacture complex peptides with high efficiency andpurity, which enables reducing the amount of solvent to be
used and even avoiding use of solvents that could cause
cancer or reproductive toxicity.
The Fujifilm Group will contribute to R&D on newpharmaceuticals and biomaterials by providing highperformance, high-purity peptides via its proprietaryprocess, which itself contributes to reducing
environmental burden.

100

Comparison of amount of solvent used

80
60
40

70 – 80%
reduction

100％

20
0

Conventional method

Fujifilm’s proprietary method

Providing technical support to disseminate chemicalsafety management in ASEAN
FUJIFILM Holdings participates in providing technicalsupport related to the handling of chemical substances in
ASEAN, an initiative led by the Ministry of Economy, Tradeand Industry (METI) of Japan.
In February 2021, Fujifilm attended a web conference
to explain its chemical risk assessment and provide a risk
assessment workshop for chemical regulatory authorities
and chemical industry associations in both Indonesia
and Thailand. This webinar was well received by theattendees for its practical content, which was offered by
a company that safely handles a wide range of chemical
substances, including reagents, chemical products andhigh-performance materials.
The Fujifilm Group will continue to take the lead incontributing to ensuring chemical safety in the supply
chain, leveraging its knowledge of chemicals management
to share necessary skills and systems.

22

FUJIFILM Holdings Corporation

Webinar held for Indonesia

Feature 2

Accelerating Solutions to Social Issues with DX
The Fujifilm Group leverages AI and other digital technologies, focusing on the creation of products
and services that contribute to digital transformation (DX), which transforms the way society andbusiness work.

The Fujifilm Group’s Approach

Tackling mounting medicalcare issues with medical
systems andAI technology
Toshiyuki Nabeta (left)

Director, Medical Systems Research & Development Center
and General Manager, IT Solutions Department,
Medical Systems Division, FUJIFILM Corporation

Masahiro Shimohori

ICT Strategy Division, FUJIFILM Holdings Corporation

Contributing to wellness in an age where
people live to 100
Nabeta In the medical field, issues are emerging in many
countries and regions such as increasing medical expenses
associated with the aging of society and population growth,
regional disparities in medical services and harsh working
environments of medical workers. Many of these issues havebeen exacerbated by the spread of COVID-19. I believe
utilization of AI technology is the key to solving these issues.

In the 1980s, Fujifilm introduced the world’s first digital
X-ray system. Instead of the film-based images that had
been used up to that point, we established a system thatcan produce a digital image on a display. Since then, we
have continued to improve our imaging and image
processing technologies and evolve our products andservices.
By combining these technologies cultivated over many
years with the cutting-edge AI technology that is effective incollecting and analyzing tremendous amounts of data, we
hope to create products and services that consistently
contribute to the healthcare-related fields of prevention,
diagnosis and treatment, thereby promoting people’s healthin an age where people live to 100.

Aiming for semi-automated diagnostic
imaging workflow
Nabeta In April 2018, Fujifilm launched medical AI
technology brand REiLI seeking to realize medical systems

that utilize AI technology.
What we aim to
do with REiLI is semiautomate the workflows
related to diagnostic
imaging in particular andprovide medical systems Medical AI technology brand REiLI
that can reduce
physician workloads. The diagnostic imaging workflows
through X-rays and CT scans include many steps: (1)examination (imaging), (2) visualization of what was
examined, (3) detection of lesions and abnormalities, (4)classification of lesions and abnormalities, and (5)production of image interpretation reports; placing a
tremendous burden on medical professionals. At Fujifilm,
we have been developing medical systems that utilize AI
technology and gradually providing them to medical
institutions since 2019 with the aim of reducing thatworkload (see figure on the next page).
Specifically, we are working on providing solutions that
support many aspects of diagnosis by combining various
functions, including (1) organ segmentation, which provides
stable visualization of organ structure without being
affected by individual differences in shape or the presenceof disease, (2) computer-aided diagnosis, which
automatically detects lesions on the image and helps
reduce the risk of them being overlooked and shorten
the time required to detect them, and (3) image
interpretation reporting workflow, which automatically
prepares a draft report based on the lesions specified
on the image.

Sustainability Report 2021

23

Activity Report

Shimohori When the topic of AI comes up, the discussion

tends to focus on whether it will or will not exceed human
intelligence, but what we aim to do at Fujifilm is support
medical professionals through the utilization of AI
technology, thereby improving the quality of medical care.
The medical professionals who use our products andservices understand that point well and have provided
feedback that our products and services reduce the risk ofoverlooking lesions, giving them peace of mind and thatthey expect to be able to deliver consistent quality of
exams and efficient training to develop human resources.
The reduction of time spent on interpreting images brings
secondary benefits such as being able to spend more timetalking with patients.

Applying the knowledge cultivated in the
medical field to other businesses to resolve
diverse social issues
Nabeta The technological strength of Fujifilm is that wehave both systems such as our X-ray and other diagnostic
imaging systems and IT solutions such as our PACS*1,
which contributes to management and sharing of
diagnostic images and other medical information andboasts the No. 1*2 share in the world. Another strength isthat we possess a wide range of technologies related toimages, including imaging technology and image
processing technology.
Shimohori Being able to bring together the diverse
knowledge and technologies within the Group and apply
them in products and services is a distinctive characteristicthat sets us apart from our competitors. The automatic
production of image interpretation draft reports mentioned
earlier was made possible through a collaboration between

Fujifilm and FUJIFILM Business Innovation (formerly Fuji
Xerox), which specializes in natural language processing
technology (see page 26 for details). Additionally, in March
2021, the Medical Division of Hitachi, Ltd., which
commercialized gastric mass screening vehicles andultrasound diagnostic equipment for the first time in theworld, deploying CT, MRI and other such products, wasadded to the Group as FUJIFILM Healthcare Corporation.
The potential for synergy has grown even further.
Nabeta We are also working on joint research and joint
development with medical institutions, research institutions
and start-up companies both in Japan and abroad.
Currently, only a part of the diagnostic imaging
workflow can be semi-automated, but our goal for the
future is to bring that up to the level where it is the ultimate
in AI technology in the medical field or, in other words,
giving structure to physician knowledge, through data
learning, including quality medical images, and image
interpretation reports.
Shimohori To use the analogy of cars, the value brought
by AI technology is similar to the essential role of car
navigation systems that allow you to make it to yourdestination quickly and reliably. There should be products
and services other than medical systems that can be madedramatically more convenient if the processes just before ahuman makes the final decision can be semi-automatedwith AI technology. Going forward, we will also set oursights on applying the know-how cultivated in medical
systems and AI technology to the various business fieldsof the Fujifilm Group and further accelerate our efforts as
a Group to resolve social issues.
* 1 Picture Archiving and Communications System* 2 According to a survey by Fujifilm (as of June 2021)

Development and launch of diagnostic imaging systems based on medical AI technology brand REiLI
April 2018

Announcement of
REiLI concept

April 2019

December 2019

May 2020

REiLI anddiagnostic imaging

REiLI andultrasound diagnostics

REiLI and X-ray
diagnostic imaging

REiLI and X-ray
diagnostic imaging

Developed SYNAPSE
SAI viewer, an AI
platform with functions
such as automatic organ
recognition on
CT images, in Japan

Launched iViz air,wireless ultrasounddiagnostic imaging
equipment with automatic
measurement function
for urine volume,in Japan

Launched a function forrecognition of surgicalgauze as a new option
on ultra-lightweightmobile digital X-ray
imaging device FUJIFILM
DR CALNEO AQRO
in Japan

Launched provision of
pulmonary nodule
detection function for AI
platform SYNAPSE
SAI viewer in JapanREiLI and endoscope
diagnostic imaging
Launched software
EW10-EC02 with CAD
EYE endoscopic image
diagnosis support systemthat supports endoscopic
lesion detection andclassification of colon
polyps (initially for Europe)≫ See pages 25−26 for more information on related products and services.

24

FUJIFILM Holdings Corporation

REiLI and X-ray
diagnostic imaging
Launched developmentof technology to support
diagnosis of COVID-19induced pneumonia
in JapanIntroduction

Medium- to LongTerm Vision

Activity Report

Medical Products and Services Utilizing AI

Utilizing AI technology to implement
functions for supporting medical settings
Supporting early detection and treatment of lung cancer: Pulmonary nodule detection andanalysis functions

Pulmonary nodules*1 show up as white shadows on thelungs in X-ray and CT images and indicate the possibility oflung cancer. Lung cancer has one of the highest mortalities
among malignant growths (tumors), and it is important todetect pulmonary nodules, which are a symptom, as earlyas possible for early detection and timely treatment.
Fujifilm utilized AI technology*2 to develop a pulmonary
nodule detection function to support diagnostic imaging
for automatic detection of possible pulmonary nodules on
CT images of the lungs, and a pulmonary nodule analysis
function to analyze pulmonary nodules confirmed by aphysician and support the preparation of a report on thephysician’s findings. These functions are designed tocontribute to reducing the workloads of physicians andstreamlining the workflows, and have been available tomedical institutions since June 2020 in Japan as
applications for Fujifilm’s AI platform that supports thediagnostic imaging workflow.

Displaying results of detection of
possible pulmonary nodules(Left: Screenshot of whole screen;
Right: Enlargement)

Contributing to the prevention of oversight: Surgical gauze recognition function

Leaving gauze in the body after a surgical procedure is aserious accident that could result in complications andinfections, so medical institutions are seeking technologythat will be of use in preventing such oversights.
In May 2020 in Japan, Fujifilm launched a function forrecognizing surgical gauze*3 that supports the confirmationof whether gauze has been left behind in the patient’s bodyafter surgery by recognizing and marking surgical gauze in
X-ray images using AI technology*2. It is an option available

COVID-19 pneumonia image analysis program

In certain cases, medical institutions perform CT scans of
the chest to go with PCR and antibody tests to check
whether a patient has COVID-19 when admitting them tothe hospital or providing emergency transport. Reducing theworkloads of medical professionals involved in diagnostic
imaging has become an issue.
Fujifilm has developed a COVID-19 pneumonia image
analysis program utilizing AI technology*2 to support
physicians in diagnostic imaging by indicating the possibility(certainty) that a chest CT image may include radiologicalfindings that are characteristic of COVID-19 pneumonia andmarking the areas related to determining the level ofwith Fujifilm’s ultra-lightweight mobile digital X-ray
imaging device.

Image showing surgicalgauze recognized andmarked on a postsurgery abdominal
X-ray image

certainty thereof. It was launched as an application for
Fujifilm’s 3D image analysis system in June 2021 in Japan.

Indicating the possibility(certainty) of a COVID-19
pneumonia ﬁnding inthree levels on the upper
right and marking thearea that contributed tothe determination ofcertainty in light blue

* 1 Refers to growths no more than 3 cm in size, sometimes smaller than 5 mm
* 2 Deep learning, which is a form of AI technology, was used in the design. System performance and accuracy do not change automatically once installed* 3 Does not guarantee the recognition of all gauze and requires a comprehensive confirmation including visual inspection of the X-ray

Topic

Development support tool for AI technology assisting diagnostic imaging developed jointly with
the National Cancer Center Japan

Fujifilm developed an AI development support platform with the National Cancer Center Japan to promote research and development ofAI technology assisting diagnostic imaging by research and medical institutions (announced in April 2021). This platform facilitates thedevelopment of AI technology (software) for assisting diagnostic imaging by physicians and researchers without requiring advanced
knowledge of programming. Both parties will utilize the platform in research and verify its usefulness, and Fujifilm will be working
on commercialization.

Sustainability Report 2021

25

Activity ReportCreating Value through Group Synergy

Supporting physicians in diagnostic imaging withtechnology for generating image interpretation reports
Diagnostic imaging via CT scan and other technologies isused in examinations for various illnesses, including
COVID-19. Essential steps include the physician inspecting
images for lesions or other abnormalities (reading the CT
image) and recording the results in a report. In recent years,
with advances in imaging devices, it has become possible
to obtain many images in a short time, but this has
increased the workloads of physicians reading the CT
images, which is a challenge at many medical sites.
The technology for generating image interpretation
reports jointly developed by Fujifilm and FUJIFILM Business
Innovation (formerly Fuji Xerox), along with a pulmonary
nodule detection function, allows for automatic detection
and analysis of possible lesions and automatic generationof an interpretation draft report based on those results (seeflow below). Not only does it reduce the workloads ofphysicians associated with reading CT images, promoting
work-style reform in medical settings, but it also leads tospending more time in communication with patients.
The main technologies supporting the generationof interpretation draft reports are Fujifilm’s image recognition
technology and FUJIFILM Business Innovation’s automatic
text generation technology. The former is technology thatwas cultivated in the photograph and medical equipment

fields and can be used to automatically find images
matching a specific description out of an enormous amountof image data. The latter is technology that automatesdocument preparation and summary of the given
description using AI. It is based on natural language
processing technology*, which was cultivated in researchand development of multifunction devices and otherdocument-related products.
The researchers of both companies formed a project
team to establish a new technology based on these whileobtaining advice from multiple physicians who read scanson a daily basis. This technology was made possible
precisely because the Fujifilm Group possesses knowledge
and technologies related to both images and language andhas an abundance of connections with medical institutions
through businesses such as diagnostic imaging equipment.
Leveraging this technology, Fujifilm began introducing
pulmonary nodule detection and analysis functions asapplications for AI platform SYNAPSE SAI viewer to medical
institutions in June 2020 in Japan. We will continue topromote unified research and development efforts
throughout the Group and expand indications.
* Technology for processing ordinary language used by humans with a computer

Flow of generating image interpretation draft reports
Input: Exam image

Labeling of a finding▶

Image recognition
system▶

Attribute nameValue

NoduleYes

Pleural inﬁltration

Yes

Other tissue inﬁltration

No

Fujifilm Strengths• Top share of medical-use PACS market in Japan• Image recognition technology cultivated in the photograph and medical equipment ﬁelds• Extensive knowledge in the medical ﬁeld accumulated in the manufacture and sale ofmedical equipment

The know-how of the automatic text generation technology of
FUJIFILM Business Innovation has contributed signiﬁcantly to
improving the ﬂuency of automatically generated draft reports, whichmakes them feel as natural as ones prepared by humans, and theappropriateness thereof with proper expression of the analysis results
without excess or deﬁciency. We will continue to bring together thediverse knowledge of Group companies as we aim to make ourtechnology for generating image interpretation reports commonplacein medical settings.

Keigo Nakamura

Imaging Technology Center,
FUJIFILM Corporation

26

FUJIFILM Holdings Corporation

AI-based output: Report▶

Text generation
system▶

Blood clot found in lung. The
pleura is drawn in and likely
inﬁltrated. No inﬁltration
found in other tissues.

FUJIFILM Business Innovation Strengths• Natural language processing technology in the document ﬁeld
• Automatic text generation technology using natural language processing technology• Hypothesis veriﬁcation capabilities and knowledge cultivated in ﬁeld tests for natural
language processing technology

Having an abundance of appropriate data is essential for AI learning inorder to improve its accuracy. In that regard, Fujiﬁlm has a solid trackrecord in joint research with medical institutions, which has enabled
efﬁcient development utilizing a tremendous amount of image dataand image interpretation reports from medical cases. We also received
cooperation from medical institutions in verifying the appropriatenessof the reports to improve the accuracy of the technology. We will seek
to apply the technology our team has perfected to ﬁelds other than
medical systems.

Tomoko Ohkuma

Imaging Technology Center,
FUJIFILM Corporation (Fuji Xerox member at the time of the project)

Introduction

Medium- to LongTerm Vision

Activity Report

Utilizing DX in Business Process Reform

Quickly digitalizing paper documents,
transforming them into true information assets
Large amounts of contracts, applications, reports andother documents are prepared on a daily basis at various
companies and public institutions. In many cases, theoriginals are still stored in hard copy format, which is one
factor that inhibits the sharing and utilization of information.
Additionally, many business processes require exchanging
paper-based documents, which creates an obstacle whenattempting to introduce new work styles such as
telecommuting.
FUJIFILM RIPCORD G.K. was established in
September 2020 through a joint venture between FUJIFILM
Business Innovation (formerly Fuji Xerox) and US-based
Ripcord, Inc. with the aim of solving such challenges. By
combining the know-how of FUJIFILM Business Innovation
cultivated in business process outsourcing services forconverting various paper records* into electronic format andstreamlining work processes with the technology of Ripcord
for quickly converting paper documents using robotics
technology and AI, we will contribute to reforming businessprocesses involving paper documents.
The service is performed according to the following
flow: (1) a dedicated robot scanning paper documents athigh speed and high image quality and converting them into
digital data, (2) AI automatically tagging and classifying
attribute data such as the title using optical character
recognition (OCR) technology to facilitate storage, searches
and utilization, and (3) managing the data in the cloud.

Processing the information without human involvement
reduces the risk of information leaks as well, securely andquickly digitalizing valuable information and releasing it to
the customer’s workflow.
The scanning process can handle several hundred
million pages, far exceeding past services that wereavailable. Another distinctive characteristic is that not onlyis the information digitalized but it is also automatically
categorized and sorted for easier utilization later. For
example, digitalizing handwritten application forms used toopen accounts at banks and increasing their searchability
will help streamline operations at branches and speed up
the provision of services to customers. In addition, atinsurance companies, digitalizing insurance claims sentfrom insureds will allow a system in which review work canbe performed anywhere. Furthermore, by coordinating with
the Medical Systems business of the Fujifilm Group,
FUJIFILM RIPCORD has enhanced its service proposals for
streamlining and improving the quality of operations at
medical sites, including digitalization of the large amount of
paper medical charts remaining at medical institutions.
The company has already begun providing services toseveral financial institutions in Japan and will graduallyroll these services out in Asia, Oceania and otherareas overseas.
* Including estimates, order forms, delivery forms, invoices and receipts

Process for digitalizing paper documents

Streamline processes
before scanning via
sensors and various
system support

Utilize dedicated carts
to smoothly load
heavy documents

Automatically perform
staple removal in thescanning process, whichused to be a manual task

Extract text from image
data using OCR and
add attributes

Automatically categorize
documents by type andupload them to the cloudUse API* connection toallow immediate utilizationof data within the workﬂow* Stands for Application Programming Interface. A system that allows different applications to be linked to each other

Companies and public institutions in Japan have the same amount of paper documents as their counterpartsin the United States, which has a much larger population than Japan. It is said that Japan is 10 years behindin converting these documents into digital data. There is a very good possibility that we can makea contribution in this ﬁeld. Furthermore, with the urgency of work-style reform, including the introduction of
telecommuting, brought on by the COVID-19 pandemic, our role has become even more important. Goingforward, in addition to expanding the regions in which we do business, we will enhance our proposals for awide range of ﬁelds faced with the challenge of digitalization.
Koichi Yamaguchi

CEO, FUJIFILM RIPCORD G.K.

Sustainability Report 2021

27

Activity Report

Establishing a DX Promotion System

Strengthening the Fujifilm Group’s DX platform toaccelerate issue resolution
With the target of a corporate transformation leveraging AI
and IoT, the Fujifilm Group launched the Strategic ICT(information and communication technology) Promotion
Project in 2014, and later in 2017 launched the Digital
Transformation Committee comprised of digital officers
appointed from each of Fujifilm’s divisions. The Group has
used these internal organizations as drivers toward solving
challenges by leveraging the latest ICTs not only in its
business activities but also in all services and operations
provided by each of its divisions. Then, in July 2021, Fujifilm
adopted the “DX Vision,” representing the Group’scommitment to further promoting DX to provide products
and services of even greater quality than ever before, and tocontinuing its work toward resolving social issues. Alongside
this vision, the Fujifilm Group newly launched the All-Fujifilm
DX Promotion Program, a company-wide DX initiative inwhich FUJIFILM Holding’s President is responsible for the
execution. This program establishes project themes withinthe “foundation” (IT Infrastructure) and each of three “pillars”(Products and Services, Operations, and Human
Resources) comprising the Fujifilm Group’s DX platform andpromotes respective activities. By strengthening thisplatform, we will not only enable provision of new added
value but also increase the speed of our management
decision-making, and accelerate our efforts to resolve
issues.

Fujifilm Group’s “DX Vision”

Fujifilm’s relentless pursuit of a better world is entrenched in the Company’s commitment to a more sustainable,
healthier, and safer future. We are well prepared for taking on the greatest challenges of our time through the use ofadvanced and digital technology, valuable and innovative products and services, and from the connected
contributions of every business, every team, and every individual at Fujifilm.

The Fujifilm Group’s DX Platform
DX Vision
Create innovative customer experiences and resolve social issues
Create new and highly profitable business models and dramatically improve productivity

Products and Services▶ Provide high-value-added

DX Platform

services utilizing AI
technology, etc.
▶ Transform business/revenue models

Operations▶ Shift to creative work throughdramatic productivity
improvements▶ Fundamentally reform
work styles

Human Resources▶ Develop and acquire diverse

DX talent▶ Optimize personnel

assignments with adata-driven approach

IT Infrastructure
Secure, flexible and robust infrastructure supporting the Fujifilm Group’s DX

Topic

Establishment of Fujifilm Group AI Policy

AI technology is expected to resolve social issues in various fields,
including healthcare. At the same time, its risk of worsening social
inequalities and disparities depending on how the technology isapplied has also been pointed out. Recognizing these concerns,
FUJIFILM Holdings established the Fujifilm Group AI Policy as
guidelines for promoting the utilization of AI technology inDecember 2020. The policy states that we will endeavor toensure fair use, respect for human rights, management of
information security, and transparency for effective andappropriate use of AI technology.

28

FUJIFILM Holdings Corporation

TopicAcquisition of DX certification from METIThe Ministry of Economy, Trade and Industry (METI) of Japan has
established a DX certification program to certify companies thathave made preparations to promote DX in accordance with the
Act on Facilitation of Information Processing. The actions by
FUJIFLM Holdings addressing the basic items of the Digital
Governance Code, which summarizes actions required ofmanagement, including establishment of a management vision
for DX, were recognized. In March 2021, the company was
selected as a certified
DX business operator.

Feature 3Fighting against COVID-19
Among the Fujifilm Group’s many innovative and significant contributions to healthcare, the company
has been engaged in the fight against COVID-19 since the virus began its global spread in 2020.
Fujifilm’s medical imaging and informatics technologies have aided clinicians in diagnosing andtreating symptoms, and the company has been a key manufacturer of pharmaceuticals as well as acontributor to the production of vaccines. Some examples of these activities are summarized here.

Contributing to Prevention of the Spread of COVID-19

Supporting vaccine development and manufacturingwith advanced technology and production
control capabilities
Progress is being made worldwide to develop and widely
deploy COVID-19 vaccines. Expanding the availability ofhighly effective vaccines is expected to prevent the spreadand reduce the severity of COVID-19, resulting in fewer
restrictions on activities and reducing social risks suchas the growing strain on healthcare systems. The Fujifilm
Group is dedicating its talents, resources and technologies
to manufacturing drug substance for vaccine candidates
to ensure a steady supply of high-quality vaccines as
quickly as possible.
In July 2020, FUJIFILM Diosynth Biotechnologies(FDB), a biopharmaceutical contract development andmanufacturing organization (CDMO), was tapped by U.S.
biotechnology company, Novavax, Inc., to manufacture
the antigen of its NVX-CoV2373 COVID-19 recombinant
protein vaccine candidate. The antigen in a vaccine is oneof the main components that generate an immune response.
In the same month, FDB began production for
Novavax’s vaccine candidate at its facility in North Carolina,
and its Texas facility began production in December 2020.
As part of the U.S. government’s Operation Warp Speed,a public-private initiative for the accelerated development
and distribution of COVID-19 vaccines and therapeutic
drugs, an agreement was signed to secure a portion of

the manufacturing capacity through the end of 2021 at the
Texas facility for the Biomedical Advanced Research andDevelopment Authority, an office of the U.S. Department of
Health and Human Services. In August 2020, FDB’s facility
in the U.K. was tapped to manufacture for Novavax’s
vaccine candidate, with production initiating in February
2021.
In Japan, Fujifilm signed an agreement withbiotechnology company VLP Therapeutics Japan (VLP
Therapeutics) in October 2020 for the manufacture of a
COVID-19 vaccine formulation. This COVID-19 vaccine isa lipid nanoparticle formulation containing self-amplifying
RNA (a replicon)*1 as the active ingredient. Going forward,
the Fujifilm Group will utilize its manufacturing equipment
and infrastructure, including the lipid nanoparticle
manufacturing equipment at FUJIFILM Toyama
Chemical’s 701 Facility, to take on everything from processdevelopment to manufacturing for clinical trials of VLP
Therapeutics’ COVID-19 vaccine formulations.
*1 RNA (ribonucleic acid) is a biopolymer composed of a base, sugar andphosphoric acid. It is a type of nucleic acid that governs genetic information. RNAthat was added with a function that causes temporary RNA proliferation in vivo
after administration is called self-amplifying RNA, or replicon.

Fujifilm Group COVID-19 vaccine development and manufacturing support activities*2
FUJIFILM Diosynth
Biotechnologies U.S.A., Inc.
(North Carolina, USA)

FUJIFILM Diosynth
Biotechnologies Texas, LLC

FUJIFILM Diosynth
Biotechnologies UK Limited

FUJIFILM,
FUJIFILM Toyama Chemical

Manufacturing of drug substance for
NVX-CoV2373 vaccine candidate
developed by US-based Novavax
launched in July 2020

Manufacturing of drug substance for
NVX-CoV2373 vaccine candidate
developed by US-based Novavax
launched in December 2020

Manufacturing of drug substance for
NVX-CoV2373 vaccine candidate
developed by US-based Novavax
launched in February 2021

Everything from processdevelopment to manufacturing forclinical trials of vaccine formulations
developed by VLP Therapeutics Japan
Photo: FUJIFILM Toyama Chemical facility*2 As of June 2021

Sustainability Report 2021

29

Activity Report

FUJIFILM Diosynth Biotechnologies plays core role in supporting vaccine manufacturing
FUJIFILM Diosynth Biotechnologies (FDB) has facilities in
the U.K., the U.S., and Denmark and provides the contractdevelopment and manufacture of various types ofbiopharmaceuticals including antibody drugs, recombinant
protein, gene therapy drugs and vaccines. Biopharmaceuticals
are proteins produced in expression systems composed ofliving organisms such as animal and insect cells as well as
microbial systems such as E. coli, to name a few. As an
industry leader with many decades of experience, FDB
provides comprehensive services including the developmentof cell lines, process development, clinical and commercial
production of biologics, vaccines and viral vectors.
Fujifilm has a legacy of advanced production
technology, cultivated in the photographic film field,
including technology for maintaining certain conditions
during manufacturing and advanced quality control.
Application of Fujifilm’s technology to expression technology
at FDB has made it possible to increase expression titers
and maximize production volumes.
Leveraging these strengths, FDB supports the
manufacturing of COVID-19 vaccines and therapeuticcandidates thus contributing to the fight against COVID-19.

FDB cellular cultivation equipment offers high productivity

Topic

For more than 30 years, FDB has been supporting partner
initiatives to provide vaccines and therapeutic drugs to people
all over the world. Our specialized knowledge and capabilities
have never been more needed than now during the COVID-19
pandemic. We are currently putting every effort into supporting
the manufacture of Novavax’s COVID-19 vaccine candidate at
our facilities in the U.S. and the U.K.
While addressing this global
crisis, FDB will lead the efforts of
the Fujifilm Group to resolve social
issues in the healthcare field,
continuing to provide therapeutic
drugs that support the lives andhealth of patients all over theworld without interruption.
Martin Meeson

President and CEO
FUJIFILM Diosynth Biotechnologies

Mobile clean rooms enable a safer and more flexible production system

U.S. President and U.K. Prime Minister visit FDB facilities

In July 2020, then U.S. President Donald Trump visited FDB’s North Carolina facility
and observed the NVX-CoV2373 drug substance manufacturing equipment,
announcing that the U.S. government would contribute roughly US$265 million to
support production. In February 2021, U.K. Prime Minister Boris Johnson visited
FDB’s U.K. facility. This visit deepened understanding of the technological andproduction control capabilities of the Fujifilm Group and built anticipation for
vaccine availability.
These visits to manufacturing facilities by government leaders showed the social
importance of developing vaccines. The Fujifilm Group will continue to work closelywith national governments and play a vital role in vaccine production.
Prime Minister Johnson on his visit to FDB’s U.K. facility

30

FUJIFILM Holdings Corporation

Introduction

Medium- to LongTerm Vision

Activity Report

Contributing to COVID-19 Diagnosis

Responding to changing situations and swiftly
providing new PCR test reagentsThe state of COVID-19 infections has been in constant flux, with mutant strains of the virus continuing to emerge; amid thissituation, FUJIFILM Wako Pure Chemical Corporation develops and supplies PCR test reagents for research use and otherproducts on short cycles, meeting the needs at hand in this ever-changing environment.

Enabling quick and accurate saliva PCR tests

Traditional PCR tests mainly use samples of mucus fromthe subject’s nose or throat. However, insertion of swabs
deep into the sinuses causes physical strain on thesubject and can put the sample-taker at risk of infection if
the subject sneezes or coughs. To address this, FUJIFILM
Wako Pure Chemical developed the SARS-CoV-2 Lysis
Buffer, a pretreatment reagent that can quickly detect
RNA from viruses by only adding the subject’s saliva.
Furthermore, its SARS-CoV-2 RT-qPCR Detection Kit Ver.
2 (for research use only) prevents false negatives* causedby the degradation of viral genes in samples, and enables
easy, rapid and highly accurate PCR testing.
* Instances where an infected subject receives a negative test result

SARS-CoV-2 RT-qPCR Detection Kit Ver.2

Providing reagents identifying mutant strains

COVID-19 is repeatedly mutating as it spreads throughout
the world, altering its pathogenic properties, infectivity andother qualities. In order to identify infection vectors andcontain the virus, it is important that PCR tests be able toascertain the state of infection, including which mutant
strain a subject has. FUJIFILM Wako Pure Chemical iscontinuing to support the fight against these mutant
strains by developing and providing a number of kitscapable of identifying each of them: the N501Y Mutation
Detection Kit for the alpha strain, the E484K Mutation
Detection Kit for the beta and gamma strains, and the
L452R Mutation Detection Kit and E484Q Mutation
Detection Kit for the delta strain (all for research use only).

Detection of mutated variants (+: Positive, –: Negative)
N501Y
E484K
L452R
E484Q
Mutation Mutation Mutation Mutation
Detection Detection Detection Detection
Kit
Kit
Kit
Kit

SARSCoV-2
Positive
SampleDetected
Variants

+

−

−

−

Alpha strain(N501Y)

+

+

−

−

Beta and Gamma
strains(N501Y and E484K)

−

−

+

−

Delta strain(L452R)

−

−

+

+

Delta strain(L452R and E484Q)

Supporting COVID-19 epidemiological studies with PCR tests
People who are deficient in the Alpha-1-antitrypsin protein(AAT) in the blood due to genetic mutation may be more
likely to suffer severe symptoms of COVID-19 infection*.
Using PCR testing to determine possible AAT genemutation can be useful in epidemiological studies of
COVID-19, but it generally takes time to obtain test results.
FUJIFILM Wako Pure Chemical used its unique design
methods to create the α1-Antitrypsin Gene Mutation (PiS,
PiZ) Detection Kit (for research use only), offering an easy
and highly accurate way to detect gene mutations. This kit
helps provide clarity to the state of COVID-19 infections.
* The carrier rate of this mutation is said to be high in Western countries.

α1-Antitrypsin Gene Mutation (PiS, PiZ) Detection Kit

Sustainability Report 2021

31

Activity Report

Contributing to Prevention of the Spread of COVID-19

Aiming to mitigate infection risk with products using
proprietary technologies
The Fujifilm Group continues to develop products in aiming to contribute to preventing the spread of COVID-19, leveraging
technologies cultivated in its photography business.

Antibacterial and antiviral films

Antibacterial and antiviral films are being utilized more andmore in touch panels in public facilities and smartphone
displays that many people interact with. Fujifilm hasdeveloped Hydro Ag+ Virus Plus, an antiviral film forcommercial use featuring long-lasting antibacterial andantiviral efficacy using the company’s proprietary Hydro Ag+
antibacterial technology. In addition to being affixed to touch
panels and other similar screens, this film is also used insplash prevention partitions in medical facilities,
convenience stores and taxis in Japan in aiming to reduce
viral counts on these surfaces and mitigate infection risk ineveryday life.

Ordinary non-hydrophilic membrane silver-based
antibacterial coating

Silver ions are released only from the antibacterial agent on
the surface

Structure of super-hydrophilic membranes using theHydro Ag+ silver-based antibacterial coating technology

Silver ions are constantly supplied to the membrane surface
from silver-based antibacterial agent in the membrane

Example of ﬁlm usage in a taxi partition

Reducing burden on medical professionals with anti-fog film
Polyethylene terephthalate (PET) film, found in many
ordinary face shields, tends to fog up from breathing or hot
air, and suffers from poor transparency and visibility. Thishas caused problems for medical staff forced to wear themfor long periods of time. To address this, the Fujifilm Groupsupplies processing manufacturers with anti-fog film to be
used for face shields supplied to medical institutions. This isa triacetate cellulose (TAC) film boasting high transparency
with our unique anti-fog treatment applied. We will continue
to provide high value-added products that are helpful to

Topic

those working on the medical front lines, utilizing
technologies we have cultivated in the field of liquid crystal
display materials.

A face shield with anti-fog ﬁlm

Fujifilm awarded certificate of gratitude by METI
for boosting production of medical supplies

The Ministry of Economy, Trade and Industry (METI) presented acertificate of gratitude to FUJIFILM Toyama Chemical Co., Ltd.,
FUJIFILM Wako Pure Chemical Corporation and FUJIFILM Wako
Chemical Corporation for increasing production of the ant-influenza
drug Avigan® and alcohol sanitizers. This certificate of gratitude is given
to companies and organizations swiftly increasing production andgreatly contributing to the stability of people’s lives in Japan in responseto the growing demand for medical supplies, driven by the
COVID-19 epidemic.

Three group companies awarded at the ceremony

32

FUJIFILM Holdings Corporation

Introduction

Medium- to LongTerm Vision

Activity Report

Appraisals and Awards
Ranking and status of SRI audit

FUJIFILM Holdings has received the following evaluations
by external organizations as a corporate group thatproactively promotes CSR actions toward sustainable
development. It is also included in the Socially Responsible
Investment (SRI) indices listed on the right.
(As of June 2021)
Evaluation for
FUJIFILM Holdings

Survey15th CSR Corporate Ranking(2021, Toyo Keizai, Inc.)

3rd out of 1,614 companies(571.2 points)
Climate Change
Water
Supply Chain(Supplier Engagement Leader)

CDP

2nd ESG Finance Awards Japan,
Environmentally Sustainable
Corporations category(Ministry of the Environment)

AーAA

Committee Chair Award(Bronze)

FTSE4Good
Global Index

FTSE Blossom
Japan Index

MSCI JapanESG SelectLeaders Index

S&P/JPX Carbon
Eﬃcient Index

CDP Water Security
A ListCDP SUPPLIERENGAGEMENT

2nd ESG FinanceAwards Japan,
Environmentally
Sustainable
Corporations category(Bronze)

Sompo Sustainability
Index

DX certiﬁcation

The 24th Environmental
Communication
Awards, Judging
Committee Special
Award for Excellence

2021 Health andProductivity StockSports Yell
Company 2021

* Please refer to the following website for each index.
https://holdings.fujiﬁ lm.com/en/sustainability/evaluation

Appraisals and awards in FY2020
Recipient

Description

Awarding entity

FUJIFILM Holdings Corporation

Received the Judging Committee Special Award at NIKKEI Smart
Work Awards 2021

Nikkei Inc.

FUJIFILM Holdings Corporation

First time selected for Health and Productivity Stock Program

Ministry of Economy, Trade andIndustry, Tokyo Stock Exchange

FUJIFILM Holdings Corporationand 18 other Group companies

19 Fujiﬁ lm Group companies certiﬁ ed as Health and Productivity
Enterprises

Ministry of Economy, Trade and Industry

FUJIFILM Toyama Chemical Co., Ltd,
Certiﬁ cate of gratitude received for increased production of Avigan ®
FUJIFILM Wako Pure Chemical Corporation, Tablet, an anti-inﬂ uenza drug, and alcohol sanitizers during the
FUJIFILM Wako Chemical Corporation
COVID-19 pandemic

Ministry of Economy, Trade and Industry

FUJIFILM Corporation

27 products received the 2020 Good Design Award, and four of themwere selected for inclusion in Good Design Best 100

Japan Institute of Design Promotion

FUJIFILM Corporation

23 products received the iF Design Award 2021, the highest number
ever

iF International Forum Design

FUJIFILM Corporation

29 products received the Red Dot Design Award 2021, the highest
number ever. FUJIFILM PROJECTOR Z8000, an ultra-short throwprojector, won the Best of the Best Award

Design Zentrum Nordrhein Westfalen

FUJIFILM Corporation

The product design of compact digital X-ray cart system FUJIFILM DRCALNEO AQRO (FDR nano) received the Minister of Economy, Trade andIndustry Award, and the Invention Implementation Achievement Award at
the National Invention Awards 2020

Japan Institute of Invention
and Innovation

FUJIFILM Corporation

Received the 2020 Minister of Agriculture, Forestry and FisheriesAward for achievements in research and development in agriculture,
forestry and ﬁ sheries (private sector) in relation to the development andimplementation of a foot-and-mouth disease antigen detection test kit

Ministry of Agriculture, Forestry and
Fisheries,
Japan Association for TechnoInnovation in Agriculture, Forestry
and Fisheries

FUJIFILM Corporation

Received the Minister of Economy, Trade and Industry Award at theJapan Association for
19th Green Sustainable Chemistry Awards for development of SUPERIA Chemical Innovation
ZN-II, a completely process-less printing plate for newspapers

FUJIFILM Kyushu Co., Ltd.

Received the FY2020 Commendation for Factories with excellent
energy management and the Minister s Award from the Ministerof Economy, Trade and Industry and was issued the Kumamoto
Prefecture Forest Absorption Certiﬁ cateFuji Xerox Co., Ltd. *1

Received the 2020 Good Design Award for the ApeosPort, ApeosPortJapan Institute of Design Promotion
VII and ApeosPort Print series and historical document reproduction
and restoration service

Fuji Xerox Co., Ltd.

Received the 2020 Nikkei Superior Products and Services Award and Nikkei Inc.
the Nikkei Business Daily Award for the CocoDesk personal workspace

Fuji Xerox Co., Ltd.

Received the Encouragement Award at the 3rd EcoPro Awards for
Iridesse™ Production Press

Sustainable Management
Promotion Organization

Fuji Xerox Co., Ltd.

Earned No. 1 rating in the J.D. Power 2020 Color MFP Customer
Satisfaction Survey (SM)J.D. Power Japan, Inc.

FUJIFILM (China) Investment Co., Ltd.

Received the CSR China Education Award

Central Committee of theCommunist Youth League

FUJIFILM (China) Investment Co., Ltd.,
Fuji Xerox (China) Ltd. *2

Received the Foreign-Invested and Hong Kong, Macao, and TaiwanInvested Enterprise Award and the Evergreen Award: One-Star atGoldenBee CSR Report Honor Roll 2020 (respectively)

China Sustainability Tribune

Fuji Xerox Korea Company Limited *3

Obtained CCM (Consumer Centered Management) Certiﬁ cation

Korea Fair Trade Commission,
Korea Consumer Agency

Ministry of Economy, Trade andIndustry,
Kumamoto Prefecture*1 now FUJIFILM Business Innovation Corp. *2 now FUJIFILM Business Innovation (China) Corp. *3 now FUJIFILM Business Innovation Korea Co., Ltd.

Sustainability Report 2021

33

Activity ReportSocial Contribution Activities
The Fujiﬁlm Group emphasizes ongoing relationships with local communities as a corporate citizen. We are engaged in
activities that take advantage of the nature of our business, such as the provision of medical equipment to emerging countries
and disaster sites, the reproduction and utilization of historical documents, and the provision of support through photographs.
In addition, we carry out activities all over the world aimed at coexistence with communities, including support for recovery andreconstruction in disaster areas and educational support.

China

Reforestation activities since 1998: Providing an online
program for raising awareness of forest regenerationin 2020

United States

Conducting environmental conservation activities incommunities via #FujifilmCares Fall Volunteer Events

In response to the COVID-19 pandemic, FUJIFILM (China) Investment Co., Ltd.
continued its volunteer tree planting activities in the Inner Mongolia Autonomous
Region online and provided an educational program for raising awareness offorest regeneration via an app. Additionally, a donation was made to partner
non-proﬁt organization Greening Network, funding the planting of 300 trees.

Portugal

Communicating the message for preventing breast
cancer worldwide via social media
During Breast Cancer Awareness Monthin October 2020, FUJIFILM EuropeGmbH – Sucursal em Portugal partneredwith non-governmental organizations
such as the Portuguese League against
Cancer to organize “Pink Day,” in which
employees wore pink to participate. The
selﬁes of all employees wearing pinkmasks were published in a shortanimation on the corporate page on
business social media platform LinkedIn,
making a worldwide appeal for breast
cancer prevention and early diagnosis.

Employees from Fujiﬁlm’s ﬁve Group companies in North America with bases ofoperation in New York and South Carolina carried out beautiﬁcation activities suchas picking up trash and planting seasonal ﬂowers in public parks. A donation was
also made for environmental conservation activities, and partnering with a local
cleanup campaign, the companies carried out volunteer activities to give backdirectly to the community as “good neighbors.”

United States

Holding events to prevent sickness during American
Heart Month in February and participating in fundraising

Vietnam

Organizing an auction for local school ﬂood relief

FUJIFILM VIETNAM Co., Ltd. held an auction to support Ba Long Primary andSecondary School in Quang Tri Province, which was damaged by the major ﬂoodin October 2020. All the money raised at the event was donated for the purchaseof desks and chairs to support the reopening of the school.

34

FUJIFILM Holdings Corporation

Group companies in North America heldinternal events for preventing heart attacks
and strokes, and more than 300 employees
took the pledge of maintaining healthy
lifestyles as a new initiative. In addition,
Americas region employees raised over
30,000 U.S. dollars through fundraising andwalking events. With company matching,a total of 42,322 dollars was donated to
non-proﬁt partners such as the American
Heart Association.

Introduction

Medium- to LongTerm Vision

Activity Report

Fujiﬁlm Group Social Contribution Policy
https://holdings.fujiﬁlm.com/en/sustainability/vision/policy/society* See also Section 4.6 Corporate Citizenship in the Sustainability Report 2021,
Management Performance.

Introducing female scientists and powerful
women from around the world

United Kingdom

Supporting online learning with content that communicatesthe joy of science to children

The February and July 2021 issues of Women4Women Magazine, which
is published by FUJIFILM Europe GmbH, included a special feature
introducing female scientists and powerful women from around theworld who are experts at the Fujiﬁlm Group or partner with the Group.
The February issue highlighted the contributions of women to sciencein commemoration of International Day for Women and Girls in Science.
The July issue focused on exciting experiences based on key words
such as commitment, resistance and focus.

To support home learning, which
has increased as a result of
COVID-19, FUJIFILM UK Ltd.
launched an online learning
hub for 5–8 year old children
to learn about the science thatpowers Fujiﬁlm technologies
from photographs to vaccines.
Educational coloring books toreengage children with learning
in a fun and exciting way
were distributed to elementary
schools in the local community
and also made available for freedownload online. Since then,translated books have also beencreated in Turkey and Germany.
In addition, FUJIFILM Diosynth
Biotechnologies created a gameapp called Virtual Victor forchildren to learn more about
gene therapy.

https://www.fujiﬁlm.com/uk/en/learning-hub

https://fujiﬁlmdiosynth.com/kids-science-portal/

February 2021: https://www.fujiﬁlm.it/women4women/second_issue/
July 2021: https://www.fujiﬁlm.it/women4women/third_issue/

Support activities during the COVID-19 pandemic

Japan

With the cooperation of non-proﬁt Single
Mothers Forum, the Fujiﬁlm Group supported
around 2,100 single-parent households every
month during the period from December
2020 to March 2021. In addition to donations
totaling JPY 21 million for the purchase ofnecessities, Fujiﬁlm disinfecting products andcosmetics were supplied.

India

Singapore

Through an NPO, National Children’s
Cafeteria Support Center, Musubie, theFujiﬁlm Group donated instax mini 11
instant cameras and ﬁlm and disinfecting
products to 200 children’s cafeteria groups
nationwide, supporting important
community network.

Fuji Xerox Singapore (now FUJIFILM Business Innovation
Singapore Pte. Ltd.) partnered with non-proﬁt TOUCH Community
Services in volunteer activities to deliver meals to homeboundelderly who were unable to go out due to COVID-19.

United States

Australia

Chester Hill High School receiving the donation

FUJIFILM India Private Limited partnered with
the Society of Indian Radiographers to expand
support for growing poverty among
underprivileged women during the COVID-19
pandemic. In addition to providing soap,
menstrual pads, and other hygiene products,
a workshop was held to educate people onbreast cancer.

FUJIFILM Holdings America Corporation and
FUJIFILM North America Corporation matchedemployee donations to provide a total of 20,000
dollars to non-proﬁt Project HOPE for the provision ofventilators, personal protective equipment (PPE), andtraining to healthcare workers in areas withinsufﬁcient service due to COVID-19.

As a corporate member of non-proﬁt Australian Business
and Community Network, which supports education,
Fuji Xerox Australia (now FUJIFILM Business Innovation
Australia Pty Ltd.) donated 150 used laptops to fourhigh schools to help eliminate the digital divide that has
become more apparent due to COVID-19.

Sustainability Report 2021

35

About the cover page

Information Disclosure Tools

GovernanceCorporate Governancehttps://holdings.fujifilm.com/en/about/governance• Corporate Governance Guidelines• Report on Corporate Governance• Fujifilm Group Tax Policy

Economic aspects
Disclosed as IR information (including governance)
FUJIFILM Holdings Corporation

SUSTAINABILITYREPORT

2021

Investor Relations
https://ir.fujifilm.com/en/investors.html

SVP Stories

Sustainability Report SVP Stories

The “I” and “F” in the middle of the FUJIFILM corporate
logo have been given an edgy touch to express ourcommitment to advanced technology. Using this as the
motif, we combined it with the six colors used in our CSR
plan, Sustainable Value Plan 2030, to emphasize ourefforts to resolve social issues with ouradvanced technology.

• Integrated Report• Securities Report (“Yukashoken Hokokusho”)

Social/Environmental aspects
Disclosed as CSR information (including governance)
Sustainability
https://holdings.fujifilm.com/en/sustainability• Sustainability Report 2021
SVP Stories / Management Performance• Site ReportManagement Performance

Sustainability ReportManagement PerformanceGRI Standards Comparison Table
https://holdings.fujifilm.com/en/sustainability/search

Please let us know your comments on this report and oursustainability activities via the form below:

https://holdings.fujifi lm.com/en/contact

FUJIFILM Holdings Corporation
ESG Division
7-3, Akasaka 9-chome, Minato-ku, Tokyo 107-0052, Japan
Tel. : +81-3-6271-2065 Fax : +81-3-6271-1190

Published: October 2021

© 2021 FUJIFILM Holdings Corporation